Robert Paul, DO
Orthopaedic Surgery · North Kansas City, MONPI 1265406250
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (49.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. Zimmer Biomet accounts for 91.4% of it on its own, with 10 other manufacturers making up the rest.
Across 87 payments — averaging $112.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$9K
- Sanara Medtech Inc.$333
- Stryker$191
- Johnson & Johnson$97
- Acumed LLC$60
- Smith+Nephew$51
- plus $114 from 5 others
What the payments were for
- Travel & lodging$4,84949%
- Food & beverage$4,87050%
- Education$771%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 72 | $8,950 |
| Sanara Medtech Inc. | 2 | $333 |
| Stryker | 3 | $191 |
| Johnson & Johnson | 2 | $97 |
| Acumed LLC | 1 | $60 |
| Smith+Nephew | 1 | $51 |
| Dynasplint Systems Inc. | 2 | $42 |
| Abbott | 1 | $25 |
| Pacira Therapeutics, Inc. | 1 | $17 |
| Bioventus LLC | 1 | $16 |
| KCI USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ROSA$2,176
- Persona Revision$1,683
- Oxford$1,063
- Persona$446
- CellerateRx$333
- ROSA-Knee$265
- Persona MC$241
- Healthloop$150
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$149
- Connected Health-MyMobility$136
- G7$136
- Connected Health-None$125
How this compares
$9,797 in reported general payments places this provider in the 65th percentile of 455 orthopaedic surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 96 | $2,060 |
| Oxycodone Hcl | 147 | $998 |
| Ondansetron OdtOndansetron | 60 | $698 |
| Tramadol Hcl | 213 | $695 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 51 | $618 |
| Gabapentin | 69 | $395 |
| Cephalexin | 13 | $337 |
| Methylprednisolone | 27 | $163 |
| Amoxicillin | 53 | $94 |
| Meloxicam | 21 | $31 |
| Clindamycin Hcl | 11 | $25 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in North Kansas City
- Kyle BuschNorth Kansas City$53K
- Matthew SmithColumbia$2.9M
- Jay KeenerSaint Louis$2.2M
- John WatsonSaint Louis$1.7M
- Peter ChalmersSaint Louis$603K
- Katherine BurnsBridgeton$491K
- Jeremy StattonLees Summit$457K
- Lionel MetzSaint Louis$428K
- Michael HellmanLees Summit$365K
- Jon CarlsonSaint Louis$354K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.